Migraine frequency Number of attacks · adults with migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Headache intensity (mean score) · adults with migraine
1 finding from 1 review
Global impression of disease · adults with migraine
1 finding from 1 review
Number experiencing adverse effects · adults with migraine
It is very uncertain whether botulinum toxin type A changes total number of participants experiencing an adverse event compared with other established prophylactic agent (very low certainty).
1 finding from 1 review
Number of migraine days per month · adults with migraine
1 finding from 1 review
Number of headache days per month: chronic migraine only · adults with migraine
1 finding from 1 review
Migraine frequency Number of attacks · adults with migraine
1 finding from 1 review
Headache intensity (mean score) · adults with migraine
1 finding from 1 review
Global impression scale · adults with migraine
1 finding from 1 review
Number experiencing adverse effects · adults with migraine
Botulinum toxin type A probably leads to higher total number of participants experiencing an adverse event compared with placebo (moderate certainty).
1 finding from 1 review
Number of migraine days per month: chronic migraine only · adults with migraine
1 finding from 1 review
Headache (frequency) · adults with migraine
1 finding from 1 review
Improvement in ocular motility (ocular alignment ≤ 10 prism dioptres). · people with sixth nerve palsy
Botulinum toxin showed no clear difference in improvement in ocular motility (ocular alignment ≤ 10 prism dioptres). compared with observation (low certainty).
1 finding from 1 review
Secondary outcome: achievement of binocular single vision · people with sixth nerve palsy
Botulinum toxin showed no clear difference in achievement of binocular single vision (fusion and stereopsis… compared with observation (low certainty).
1 finding from 1 review
Improvement in functional ability · people with sixth nerve palsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with sixth nerve palsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events. · people with sixth nerve palsy
1 finding from 1 review
Prostatitis symptoms Subgroup: Intraprostatic injection, participants age > 50 years old, basal NIH‐CPSI score > 30 · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Prostatitis symptoms Subgroup: Pelvic floor muscles injection, participants age < 50 years old, basal NIH‐CPSI score < 30 · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Botulinum toxin A showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review